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1 Supporting figures
Figure S1: Transferring yPR65-277az into pRSF-oRibo-Q1-oGST using (a) SwaI/SpeI restriction cloning, (b) the Fastclone
method [1], or (c) In-Fusion cloning. Shown are BamHI restriction digests of plasmids derived from 8 bacterial colonies each,
together with a digest of a control plasmid (C, pRSF-oRibo-Q1-oGST-PR655/588TAG). The frequency of obtaining a correct
plasmid using restriction cloning was very low and many recombination events were observed. Only pRSF-oRibo-Q1-oGST-
PR655/588TAG was obtained using this method. The Fastclone method did not yield any correct clones, whereas In-Fusion
cloning normally produces the required construct in 80-100% of the cases. MW - molecular weight marker (Invitrogen 1kb
Plus).
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Figure S2: Tandem mass-spectrometry of PR65 peptides with UAAs incorporated at positions 5 and 588 (arrows). Shown are
the N-/C-terminal peptides of alkPR65 (a,b), azPR65 (c,d), and cycPR65 (e,f). The figure was provided by the PNAC Facility
of the Biochemistry Department, University of Cambridge.
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Figure S3: MALDI mass-spectrometry of modified oligonucleotides (a) DBCO-oligo (b) tetrazine oligo. The figure was
provided by the PNAC Facility of the Biochemistry Department, University of Cambridge.
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Figure S4: Example of click reactions using 100 µM 5-FAM azide or 3’-azide DNA oligo and 5 µ PR655/588 bearing alkyne
moieties. Reactions were performed in PBS or MES buffer. Click-mix concentrations are given in fold excess of the standard
CM-A concentration (click-mix containing 250 mM NaAsc).
Figure S5: Click reactions of azide-oligo and 5-FAM-alkyne with increasing concentrations of CM-A (click-mix containing
250 mM NaAsc) on an unstained 1% agarose gel. Click-mix concentrations are given in fold excess of CM-A.
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Figure S6: Each peptide containing azido-propargyllysine (arrows) is accompanied by a similar-size signal of -25.99amu
resulting from the reduction of azide to amine. The figure was provided by the PNAC Facility of the Biochemistry Department,
University of Cambridge.
(a) (b)
(c)
Figure S7: Full gels of Figure 3 in the main paper. SPAAC and IED-DA between azide or cyclopropene containing
PR655/588TAG and TAMRA or oligo. (a) Example reactions using 5 µM protein and 20 µM TAMRA or oligo (b) Same reac-
tions as in (a), incubated over night. (c) Chromatogram of a large scale reaction of 10 µM azPR65az and 40 µM DBCO-oligo
incubated over night at 25◦C, separated on a S200 10/300 GL. The smaller peak doublet preceding the oligo peak corresponds
protein conjugated to two oligos (x) and one oligo (o). Un-reacted protein can be detected by SDS-PAGE even though a clear
A280 peak is not visible (*, inset).
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Figure S8: Sfp-synthase mediated attachment of 20 µM CoA-oligos to 10 µM of protein bearing N- and C-terminal ybbR-
tags after an over-night incubation at room temperature (L). Lanes 1-11 are consecutive elution fractions after HPLC. Protein
conjugated to two oligos (x) and one oligo (o) are present.
Figure S9: Combining CoA-ybbR and SPAAC conjugations. Conjugations of yPR65-277az to DBCO- and CoA oligonu-
cleotides after 2 hours (left) and over-night incubation (right).
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Figure S10: DNA handle hybridization to SPAAC, IE-DA and Sfp-mediated protein-oligo conjugations purified using an S200
10/300 GL column and detected by agarose gel electrophoresis. Shown are hybridization products between varying amounts of
protein from two different fractions to double stranded DNA handles.
Figure S11: Representative full-length force extension curves of the same molecule for each PR65 attachments. Unfolding
traces are coloured in darker shades, while refolding traces are coloured in lighter shades. All traces were taken at pulling speeds
of 10 nm s−1.
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Figure S12: Two representative stretch-relax cycles of four yPR65-277az molecules. All data shown were obtained at pulling
velocities of 10 nm s−1.
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2 Supporting tables
Table S1: Equilibrium denaturation three-state fit parameters of PR65 variants. The parameters represent averages ± s.e.m.
of three technical replicates.
D50%−1 m1 D50%−2 m2
Protein [M] [kcal mol−1 M−1] [M] [kcal mol−1 M−1]
PR65 2.24 ± 0.06 2.51 ± 0.09 5.13 ± 0.03 1.40 ± 0.02
yPR65y 2.14 ± 0.06 2.48 ± 0.06 5.20 ± 0.05 1.16 ± 0.06
Table S2: List of DNA oligonucleotides (5’ to 3’). * indicates sites of modification
Name Sequence
PR65 D5TAG Fwd TAGGGCGACGACTCGCTGTACCCC
PR65 D5TAG Rev GGCCGCCGCCATATGATGATGATGG
PR65 L588TAG Fwd TAGGCCCACCACCACCACCACC
PR65 L588TAG Rev AGACAGAACAGTCAGAGCCTCCTGGGC
PR65 E277 Fwd TAGATCACCAAGACAGACCTGGTC
PR65 E277 Rev AGGCCCCACTGCTTTCTGG
oRibo Inf SwaI Fwd TCATAAAACATATTTAAATGGTGATCATGTAACCCATCC
oRibo Inf SpeI Rev GTACGGCCGACTAGTTCAGTGGTGGTG
GTGGTGGTGGGCGAGAG
PR65 NybbR Fwd GATTCTCTTGAATTTATTGCTAGTAAGC
TTGCGATGGCGGCGGCCGACGGCGACG
PR65 NybbR Rev GGATCCACGCGGAACCAGATCCGATTTTGG
PR65 CybbR Fwd CACCACCACCACCACCACTGAAAGC
PR65 CybbR Rev CGCAAGCTTACTAGCAATAAATTCAAGAG
AATCGGCGAGAGACAGAACAGTCAGAGC
DNA-protein coupling GGCAGGGCTGACGTTCAACCAGACCAGCGAGTCG*
Biotin/digoxigenin *GGCGA*CTGG*CGTTGATTTG
Abasic CGACTCGCTGGTCTGGTTGAACGTCAGCCC
TGCC*CCTGCCCGGCTCTGGACAGG
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3 Supporting methods
3.1 Expression and purification of Sfp-synthase
The pCK plasmid containing Sfp-synthase-H6 was a kind gift from the Gaub laboratory (Ludwig Maximilian
Universität, München, Germany). The previously published protocol for the production of Sf-synthase [2]
was adapted as follows: For expression, the plasmid was transformed into chemically competent C41 E. coli
and plated onto LB Agar containing Ampicillin. All colonies from the plate were used to inoculate 1 l of
2xYT. Protein expression was induced at OD600 ∼ 0.6 by the addition of 1 mM IPTG and followed by further
incubation at 25◦C overnight. Following centrifugation, the pellet was resuspended in lysis buffer (20 mM
Tris-HCl pH 7.5, 500 mM NaCl, 5 mM imidazole) containing protease inhibitor cocktail and DnaseI, lysed as
described above and centrifuged again to remove cell debris. The soluble protein fraction was filtered through
a 0.22 µm PES membrane and applied to a 5 ml HisTrap Excel column (GE Healthcare) equilibrated in lysis
buffer. After washing with 20 column volumes of buffer, Sfp was eluted in one step using 20 mM Tris-HCl
pH 8.0, 300 mM imidazole, 300 mM NaCl, 2 mM EDTA. The elution fractions were analysed by SDS-PAGE
and those containing protein at >90% purity were pooled. This solution was then split in half and dialysed
twice against either 10 mM Tris-HCl pH 7.5 or PBS pH 7.4 containing 1 mM EDTA and 10% (v/v) glycerol.
Protein was flash-frozen after concentration using a Vivaspin R©centrifugal concentrator and stored at -80◦C.
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